Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.00 Million ≈ $12.88 Million USD) by net assets (CN¥4.13 Billion ≈ $603.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002317 company net worth for the company's overall valuation and market capitalisation.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Guangdong Zhongsheng Pharmaceutical Co L to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brederode SA
BR:BREB
|
0.000x |
|
AIR CHINA LTD H ADR/20
F:AD2B
|
N/A |
|
Becle S.A.B. de C.V
MX:CUERVO
|
0.026x |
|
National Storage REIT
AU:NSR
|
0.018x |
|
Virbac SA
PA:VIRP
|
0.023x |
|
Vidrala SA
MC:VID
|
0.048x |
|
Red Rock Resorts Inc
NASDAQ:RRR
|
0.541x |
|
Schneider National Inc
NYSE:SNDR
|
0.056x |
Annual Cash Flow Conversion Efficiency for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. View Guangdong Zhongsheng Pharmaceutical Co L share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.01 Billion ≈ $586.81 Million |
CN¥337.84 Million ≈ $49.44 Million |
0.084x | +100.03% |
| 2023-12-31 | CN¥4.53 Billion ≈ $662.25 Million |
CN¥190.61 Million ≈ $27.89 Million |
0.042x | +154.87% |
| 2022-12-31 | CN¥3.82 Billion ≈ $558.47 Million |
CN¥63.07 Million ≈ $9.23 Million |
0.017x | -90.61% |
| 2021-12-31 | CN¥3.54 Billion ≈ $517.74 Million |
CN¥622.77 Million ≈ $91.13 Million |
0.176x | +359.44% |
| 2020-12-31 | CN¥3.63 Billion ≈ $530.67 Million |
CN¥138.93 Million ≈ $20.33 Million |
0.038x | -36.93% |
| 2019-12-31 | CN¥4.13 Billion ≈ $605.00 Million |
CN¥251.16 Million ≈ $36.75 Million |
0.061x | -26.56% |
| 2018-12-31 | CN¥3.95 Billion ≈ $578.14 Million |
CN¥326.78 Million ≈ $47.82 Million |
0.083x | -16.59% |
| 2017-12-31 | CN¥3.73 Billion ≈ $545.87 Million |
CN¥369.91 Million ≈ $54.13 Million |
0.099x | +0.37% |
| 2016-12-31 | CN¥3.42 Billion ≈ $501.07 Million |
CN¥338.28 Million ≈ $49.50 Million |
0.099x | +8.41% |
| 2015-12-31 | CN¥2.11 Billion ≈ $308.69 Million |
CN¥192.25 Million ≈ $28.13 Million |
0.091x | +72.01% |
| 2014-12-31 | CN¥1.90 Billion ≈ $277.85 Million |
CN¥100.60 Million ≈ $14.72 Million |
0.053x | -16.77% |
| 2013-12-31 | CN¥1.74 Billion ≈ $255.05 Million |
CN¥110.95 Million ≈ $16.23 Million |
0.064x | -29.06% |
| 2012-12-31 | CN¥1.59 Billion ≈ $232.18 Million |
CN¥142.38 Million ≈ $20.83 Million |
0.090x | +87.87% |
| 2011-12-31 | CN¥1.48 Billion ≈ $216.16 Million |
CN¥70.56 Million ≈ $10.32 Million |
0.048x | -27.79% |
| 2010-12-31 | CN¥1.39 Billion ≈ $202.91 Million |
CN¥91.72 Million ≈ $13.42 Million |
0.066x | -15.09% |
| 2009-12-31 | CN¥1.30 Billion ≈ $189.52 Million |
CN¥100.89 Million ≈ $14.76 Million |
0.078x | -81.57% |
| 2008-12-31 | CN¥172.40 Million ≈ $25.23 Million |
CN¥72.86 Million ≈ $10.66 Million |
0.423x | +11.80% |
| 2007-12-31 | CN¥130.56 Million ≈ $19.11 Million |
CN¥49.35 Million ≈ $7.22 Million |
0.378x | +192.84% |
| 2006-12-31 | CN¥138.72 Million ≈ $20.30 Million |
CN¥17.91 Million ≈ $2.62 Million |
0.129x | -- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.